$JNJ 3 SEC Filings

Filed On	Filing
01 Sep 2026	Form 3: Cavanaugh Thomas, EVP WW Chair, Innovative Med. Holds 71 shares of Common Stock
15 Sep 2025	Form 3: Morikis John G, Director Holds 598.51 shares of Common Stock
08 Jul 2025	Form 3: Pinto Daniel E, Director Holds 0 shares of Common Stock
09 Oct 2024	Form 3: Mulholland Kristen, EVP, Chief HR Officer Holds 11,689 shares of Common Stock
10 Apr 2024	Form 3: Johnson & Johnson, 10% owner and 1 other · Contineum Therapeutics Inc Holds 1,979,173 shares of Class A Common Stock
08 Dec 2023	Form 3: Woods Eugene A., Director No securities owned
02 Nov 2023	Form 3: Schmid Timothy, EVP, WW Chair, MedTech Holds 8,979 shares of Common Stock
03 May 2023	Form 3: Johnson & Johnson, 10% owner · Kenvue Inc Holds 1,716,160,000 shares of Common Stock
13 Apr 2023	Form 3: Reed John C, EVP, Pharmaceuticals R&D Holds 306 shares of Common Stock
22 Feb 2023	Form 3: Johnson Paula A, Director Holds 100 shares of Common Stock
14 Nov 2022	Form 3: Johnson & Johnson, 10% owner and 1 other · MeiraGTx Holdings PLC Holds 6,641,064 shares of Ordinary Shares
26 Oct 2022	Form 3: Forminard Elizabeth, Executive VP, General Counsel Holds 3,211 shares of Common Stock
25 Feb 2022	Form 3: Adamczyk Darius, Director Holds 1,063 shares of Common Stock
13 Jan 2022	Form 3: Hait William, See Remarks Holds 223,158 shares of Common Stock
13 Jan 2022	Form 3: Swanson James D., EVP, Chief Information Officer Holds 1,084 shares of Common Stock
13 Jan 2022	Form 3: Broadhurst Vanessa, EVP, Global Corp Aff. Holds 12,486 shares of Common Stock
13 Jan 2022	Form 3: Mammen Mathai, EVP, Pharm, R&D Holds 32,477 shares of Common Stock
29 Jun 2021	Form 3: Johnson & Johnson, 10% owner and 1 other · Cvrx, Inc
10 Dec 2020	Form 3: West Nadja, Director No securities owned
25 Jun 2020	Form 3: Johnson & Johnson, 10% owner and 1 other · Fusion Pharmaceuticals Inc.

Comments